KR20230010471A - Cosmetic composition comprising champsocephalus gunnari extract or notothenia rossii extract as an active ingredient for improving wrinkles - Google Patents
Cosmetic composition comprising champsocephalus gunnari extract or notothenia rossii extract as an active ingredient for improving wrinkles Download PDFInfo
- Publication number
- KR20230010471A KR20230010471A KR1020210091068A KR20210091068A KR20230010471A KR 20230010471 A KR20230010471 A KR 20230010471A KR 1020210091068 A KR1020210091068 A KR 1020210091068A KR 20210091068 A KR20210091068 A KR 20210091068A KR 20230010471 A KR20230010471 A KR 20230010471A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- present
- cosmetic composition
- antarctic
- water
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 103
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 230000037303 wrinkles Effects 0.000 title claims abstract description 23
- 241001459541 Notothenia rossii Species 0.000 title claims abstract description 17
- 241000509536 Champsocephalus gunnari Species 0.000 title claims abstract description 16
- 239000004480 active ingredient Substances 0.000 title claims abstract description 16
- 241000251468 Actinopterygii Species 0.000 claims abstract description 48
- 230000000694 effects Effects 0.000 claims abstract description 21
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims abstract description 15
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims abstract description 15
- 230000036570 collagen biosynthesis Effects 0.000 claims abstract description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 41
- 241001062472 Stokellia anisodon Species 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000009472 formulation Methods 0.000 claims description 16
- 239000006210 lotion Substances 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 239000000686 essence Substances 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 210000004709 eyebrow Anatomy 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000007764 o/w emulsion Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000007762 w/o emulsion Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 claims description 2
- 239000005445 natural material Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000001629 suppression Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 52
- 235000019688 fish Nutrition 0.000 description 47
- 210000004556 brain Anatomy 0.000 description 25
- 210000004185 liver Anatomy 0.000 description 23
- 210000002784 stomach Anatomy 0.000 description 20
- 230000001965 increasing effect Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 108010035532 Collagen Proteins 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 230000003833 cell viability Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- -1 retinoids Chemical compound 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 108010050808 Procollagen Proteins 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 229940081733 cetearyl alcohol Drugs 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 3
- 229940108623 eicosenoic acid Drugs 0.000 description 3
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 229940079894 benzophenone-9 Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000001120 cytoprotective effect Effects 0.000 description 2
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 2
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 2
- XCABOFSRDYPXIC-SVMKZPJVSA-N docos-2-enoic acid;(z)-docos-13-enoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC=CC(O)=O.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O XCABOFSRDYPXIC-SVMKZPJVSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- SBHCLVQMTBWHCD-METXMMQOSA-N (2e,4e,6e,8e,10e)-icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O SBHCLVQMTBWHCD-METXMMQOSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-UHFFFAOYSA-N 9,12-Octadecadienoic Acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- PHYVVEKHIKPGCF-VKLINIEKSA-N C(C=CCCCCCCCCCCC)(=O)O.C(CCCCCCC\C=C/CCCC)(=O)O.C(CCCCCCC\C=C/CCCC)(=O)O Chemical compound C(C=CCCCCCCCCCCC)(=O)O.C(CCCCCCC\C=C/CCCC)(=O)O.C(CCCCCCC\C=C/CCCC)(=O)O PHYVVEKHIKPGCF-VKLINIEKSA-N 0.000 description 1
- OPEJUSTZUUTXQB-UHFFFAOYSA-N C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(C=CCCCCCCCCCCCCCCC)(=O)O Chemical compound C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(C=CCCCCCCCCCCCCCCC)(=O)O OPEJUSTZUUTXQB-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- JIWBIWFOSCKQMA-LTKCOYKYSA-N all-cis-octadeca-6,9,12,15-tetraenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O JIWBIWFOSCKQMA-LTKCOYKYSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHYOQNUELFTYRT-DPAQBDIFSA-N cholesterol sulfate Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 BHYOQNUELFTYRT-DPAQBDIFSA-N 0.000 description 1
- 229940080277 cholesteryl sulfate Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- OTKJDMGTUTTYMP-UHFFFAOYSA-N dihydrosphingosine Natural products CCCCCCCCCCCCCCCC(O)C(N)CO OTKJDMGTUTTYMP-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- KUHNHCYDVXKZLY-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O KUHNHCYDVXKZLY-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- VKOBVWXKNCXXDE-UHFFFAOYSA-N ethyl stearic acid Natural products CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- JIWJWLDXFNQJRD-UULNMNGPSA-N hexadec-2-enoic acid;(z)-hexadec-9-enoic acid Chemical compound CCCCCCCCCCCCCC=CC(O)=O.CCCCCC\C=C/CCCCCCCC(O)=O JIWJWLDXFNQJRD-UULNMNGPSA-N 0.000 description 1
- RMMMJEMNGXIIPT-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O RMMMJEMNGXIIPT-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- NHXTZGXYQYMODD-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCC(O)=O NHXTZGXYQYMODD-UHFFFAOYSA-N 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- JBXYCUKPDAAYAS-UHFFFAOYSA-N methanol;trifluoroborane Chemical compound OC.FB(F)F JBXYCUKPDAAYAS-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940042880 natural phospholipid Drugs 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- OYNWCMHUGVQVOF-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O OYNWCMHUGVQVOF-UHFFFAOYSA-N 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- GBRFGNCKUASFCC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O GBRFGNCKUASFCC-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 남극 메켈 빙어(Champsocephalus gunnari) 추출물 또는 남극 대리석무늬 암치(Notothenia rossii) 추출물을 유효성분으로 포함하는 피부 주름개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin wrinkles comprising an extract of Antarctic Meckel's smelt ( Champsocephalus gunnari ) or an extract of Antarctic marbled female fish ( Notothenia rossii ) as an active ingredient.
피부는 외부환경과 직접 접해 있으면서 온도, 습도, 항원 및 자외선 등으로부터 보호해 주는 기능을 가지고 있다. 하지만, 외부 오염물질, 자외선, 스트레스 등의 물리적, 화학적 자극으로 인하여 피부 기능이 저하되어 나이가 들어감에 따라 세포 증식 및 면역 활성이 약해져 피부 세포의 손상을 신속히 복구하지 못하고 피부 구성 성분의 전체적인 악화를 일으켜 피부주름, 탄력 손실 및 각질화 등이 일어나게 된다.The skin has the function of protecting against temperature, humidity, antigens and ultraviolet rays while being in direct contact with the external environment. However, due to physical and chemical stimuli such as external pollutants, ultraviolet rays, and stress, skin function is deteriorated, and cell proliferation and immune activity are weakened with age, so damage to skin cells cannot be quickly restored and the overall deterioration of skin components This causes wrinkles, loss of elasticity, and keratinization of the skin.
피부의 노화는 크게 내인적 노화와 외인적 노화로 나뉜다. 내인적 노화는 자연적으로 나타나는 노화 현상으로, 임상학적으로 탄력이 감소하고 피부의 결이 거칠어지며 깊은 주름이 생기고 색소가 침착되는 특징이 있다. 외인적 노화는 자외선, 활성 산소종(Reactive oxygen species) 및 스트레스 등의 외부 환경적인 요인에 의해 발생하는 노화 현상으로 최근에는 급속한 산업화와 이에 의한 공기오염과 오존층의 파괴로 UV 양이 증가되고 이는 활성산소종과 같은 강력한 산화 물질들을 발생시켜서 피부 콜라겐 등의 결합조직형성 파괴, 세포막 기능저해, DNA 변이촉진, 단백질 작용 변형, 세포내 신호전달 물질들의 변형 등을 유발하여 인간에게 피부주름 생성, 색소 침착 등을 유발시켜 피부노화를 야기 시키게 된다. 이러한 피부 손상을 방지하기 위하여 레티놀, 레티노이드, 비타민 C, 플라보노이드 및 토코페롤, 코엔자임 Q10 등의 여러 가지 피부 보호 성분이 함유된 화장료 또는 피부 보호제가 개발되고 있다.Skin aging is largely divided into intrinsic aging and extrinsic aging. Intrinsic aging is a naturally occurring aging phenomenon, clinically characterized by a decrease in elasticity, rough skin texture, deep wrinkles, and pigmentation. Extrinsic aging is an aging phenomenon caused by external environmental factors such as ultraviolet rays, reactive oxygen species, and stress. In recent years, the amount of UV has increased due to rapid industrialization, air pollution, and destruction of the ozone layer. By generating strong oxidizing substances such as oxygen species, it induces destruction of connective tissue formation such as skin collagen, inhibition of cell membrane function, acceleration of DNA mutation, modification of protein action, and modification of intracellular signaling substances, resulting in wrinkle formation and pigmentation in humans. etc., causing skin aging. In order to prevent such skin damage, cosmetics or skin protection agents containing various skin protection ingredients such as retinol, retinoids, vitamin C, flavonoids, tocopherol, and coenzyme Q10 have been developed.
특히 태양광의 자외선(ultraviolet rays; UV)은 잘 알려진 노화 원인의 하나로 장시간 자외선에 노출된 피부는 각질층이 두꺼워지고 피부의 주요 구성요소인 콜라겐과 엘라스틴이 변성되어 피부의 탄력성을 잃어가게 된다. 콜라겐과 엘라스틴은 여러 가지 요인에 의해서 조절되는데, 콜라게나아제(collagenase)와 엘라스타아제(elastase) 같은 메탈로프로테아제(matrix metallo protease)의 발현으로 인하여 생성된 콜라겐과 엘라스틴이 분해되어 결과적으로 피부 내의 콜라겐 함량이 줄어드는 현상이 나타나게 된다. 이러한 탄력감소의 원인이 되는 콜라겐 및 엘라스틴의 감소를 억제하려는 목적으로 여러 가지 물질들이 개발되어 사용되고 있는데, 그 중 레티놀과 레티노익산 등이 탄력개선 효과를 나타내고 레구미노사 종자(Leguminosae Seeds)에서 얻어진 단백질 분획도 탄력증대 효과를 나타내는데 응용되고 있다. 그러나 이들 레티노이드들은 극소량만을 피부에 적용해도 피부 자극 및 알러지에 민감하다는 단점이 있다.Particularly, ultraviolet rays (UV) of sunlight are one of the well-known causes of aging, and in the skin exposed to ultraviolet rays for a long time, the stratum corneum thickens, and collagen and elastin, which are the main components of the skin, are denatured and lose elasticity of the skin. Collagen and elastin are regulated by various factors. Expression of matrix metallo proteases such as collagenase and elastase degrade collagen and elastin, resulting in A decrease in collagen content occurs. Various substances have been developed and used for the purpose of suppressing the reduction of collagen and elastin, which are the cause of such a decrease in elasticity. It is also applied to show the effect of increasing elasticity. However, these retinoids have the disadvantage of being sensitive to skin irritation and allergies even when only a small amount is applied to the skin.
최근에는 독성이 상대적으로 적고 자연친화적인 화장품을 개발하기 위해 천연물을 이용 추출공정과 발효기술을 통해 미백, 항노화, 항주름, 항산화, 항염과 같은 생리 활성 물질을 탐색한 후, 이들을 화장품 소재로서 사용하고 있다.Recently, after exploring physiologically active substances such as whitening, anti-aging, anti-wrinkle, anti-oxidation, and anti-inflammation through extraction process and fermentation technology using natural substances to develop cosmetics that are relatively less toxic and nature-friendly, they are used as cosmetic materials. are using
한편, 남극 메켈 빙어(Champsocephalus gunnari) 또는 남극 대리석무늬 암치(Notothenia rossii)는 해양 생물자원으로써 남극에서만 서식하는 어류이다.On the other hand, Antarctic Meckel smelt ( Champsocephalus gunnari ) or Antarctic marbled female fish ( Notothenia rossii ) are fish that live only in Antarctica as marine living resources.
이에 본 발명자들은 생체에 부작용이 없으면서 피부주름 개선 효과가 우수한 천연물질을 찾고자 모색하던 중, 남극 어류에 주목하여 이의 약리학적 효과를 실험한 결과, 남극 메켈 빙어(Champsocephalus gunnari) 또는 남극 대리석무늬 암치(Notothenia rossii)로부터 추출된 추출물의 경우 매우 낮은 농도에서 콜라겐 생합성 증대 효과 및 MMP-1 저해 활성이 우수할 뿐 아니라, 자외선(UVB)으로부터 세포를 보호하는 효과를 가짐에 따라, 피부 주름개선을 위한 기능성 화장품 소재로서의 충분한 가치가 있음을 확인함으로써 본 발명을 완성하였다.Accordingly, the inventors of the present invention, while searching for a natural substance with excellent skin wrinkle improvement effect without side effects in the body, paid attention to Antarctic fish and experimented on its pharmacological effect. Notothenia rossii ) has excellent collagen biosynthesis enhancement effect and MMP-1 inhibitory activity at very low concentrations, and also has the effect of protecting cells from ultraviolet (UVB), so it has functionality for improving skin wrinkles The present invention was completed by confirming that there is sufficient value as a cosmetic material.
따라서 본 발명의 목적은 피부 주름을 효과적으로 개선시킬 수 있는 화장료 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a cosmetic composition capable of effectively improving skin wrinkles.
상기와 같은 본 발명의 목적을 달성하기 위해서,In order to achieve the object of the present invention as described above,
본 발명은 남극 메켈 빙어(Champsocephalus gunnari) 추출물 또는 남극 대리석무늬 암치(Notothenia rossii) 추출물을 유효성분으로 포함하는 피부 주름개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for improving skin wrinkles comprising an extract of Antarctic Meckel's smelt (Champsocephalus gunnari ) or an extract of Antarctic marble-patterned female fish ( Notothenia rossii ) as an active ingredient.
본 발명의 일실시예에 있어서, 상기 추출물은 탄소수 1 내지 4의 저급 알코올, 에틸아세테이트, 아세톤, 물 및 헥산으로 이루어진 군으로부터 선택된 1종 이상의 용매로 추출될 수 있다.In one embodiment of the present invention, the extract may be extracted with one or more solvents selected from the group consisting of lower alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, water and hexane.
본 발명의 일실시예에 있어서, 상기 추출물은 콜라겐 생합성 증대 효과 및 MMP-1 저해 활성을 가질 수 있다.In one embodiment of the present invention, the extract may have a collagen biosynthesis enhancing effect and MMP-1 inhibitory activity.
본 발명의 일실시예에 있어서, 상기 추출물은 자외선으로부터 세포를 보호하는 효과를 가질 수 있다.In one embodiment of the present invention, the extract may have an effect of protecting cells from ultraviolet rays.
본 발명의 일실시예에 있어서, 상기 화장료 조성물은 유연 화장수, 젤, 수용성 리퀴드, 밀크로션, 영양크림, 마사지 크림, 에센스, 수중유 형 에멀젼, 유중수 형 에멀젼, 페이스크성 무수 생성물, 고체 무수 생성물, 소구체를 사용한 수성 상에서의 오일 분산물, 이온성 지질 소포체, 비이온성 지질 소포체, 연고, 클렌징 폼, 클렌징 워터, 팩, 보디오일, 수중유 형 메이크업베이스, 유중수 형 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도우, 마스카라, 치크칼라 및 아이브로우펜슬류로 이루어진 군 중에서 선택되는 1종의 제형일 수 있다.In one embodiment of the present invention, the cosmetic composition is flexible lotion, gel, water-soluble liquid, milk lotion, nourishing cream, massage cream, essence, oil-in-water emulsion, water-in-oil emulsion, face-type anhydrous product, solid anhydrous product , Oil dispersion in aqueous phase using spherules, ionic lipid vesicles, nonionic lipid vesicles, ointments, cleansing foams, cleansing water, packs, body oils, oil-in-water makeup bases, water-in-oil makeup bases, foundations, toners It may be one type of formulation selected from the group consisting of cover, lipstick, lip gloss, face powder, two-way cake, eye shadow, mascara, cheek color, and eyebrow pencil.
본 발명의 남극 메켈 빙어(Champsocephalus gunnari) 추출물 또는 남극 대리석무늬 암치(Notothenia rossii) 추출물은 매우 낮은 농도에서도 콜라겐 생합성 증대 효과 및 MMP-1 저해 활성이 우수할 뿐 아니라, 자외선(UV)으로부터 세포를 보호하는 효과를 갖는바, 이를 유효성분으로 포함하는 조성물의 경우 주름개선을 위한 기능성 화장료 조성물로서 유용하게 사용될 수 있다. 특히, 본 발명의 상기 추출물은 남극 어류로부터 유래한 천연 소재로서, 이를 포함하는 본 발명의 화장료 조성물은 장기간 사용에도 안전한 이점을 가진다.The Antarctic Meckel smelt ( Champsocephalus gunnari ) extract or the Antarctic marbled female fish ( Notothenia rossii ) extract of the present invention is excellent in collagen biosynthesis increasing effect and MMP-1 inhibitory activity even at very low concentrations, and protects cells from ultraviolet (UV) In the case of a composition containing this as an active ingredient, it can be usefully used as a functional cosmetic composition for wrinkle improvement. In particular, the extract of the present invention is a natural material derived from Antarctic fish, and the cosmetic composition of the present invention containing it has the advantage of being safe for long-term use.
도 1은 본 발명의 남극 어류 추출물(25μg/ml)의 MMP-1 저해 활성을 나타내는 그래프이다(1: CG 피부, 2: CG 뇌, 3: CG 간, 4: CG 위, 5: NR 피부, 6: NR 뇌, 7: NR 간, 8: NR 위, CG: Champsocephalus gunnari, NR: Notothenia rossii).
도 2는 본 발명의 남극 어류 추출물(25μg/ml)의 콜라겐 생합성 증대 효과를 나타내는 그래프이다(1: CG 피부, 2: CG 뇌, 3: CG 간, 4: CG 위, 5: NR 피부, 6: NR 뇌, 7: NR 간, 8: NR 위, CG: Champsocephalus gunnari, NR: Notothenia rossii).
도 3은 UVB(125 mJ/cm2) 조사 후 본 발명의 남극 어류 추출물(25μg/ml) 처리에 따른 세포생존율을 측정한 결과이다(1: CG 피부, 2: CG 뇌, 3: CG 간, 4: CG 위, 5: NR 피부, 6: NR 뇌, 7: NR 간, 8: NR 위, CG: Champsocephalus gunnari, NR: Notothenia rossii).
도 4는 UVB(144 mJ/cm2) 조사 후 본 발명의 남극 어류 추출물(25μg/ml) 처리에 따른 세포생존율을 측정한 결과이다(1: CG 피부, 2: CG 뇌, 3: CG 간, 4: CG 위, 5: NR 피부, 6: NR 뇌, 7: NR 간, 8: NR 위, CG: Champsocephalus gunnari, NR: Notothenia rossii).1 is a graph showing the MMP-1 inhibitory activity of the Antarctic fish extract (25 μg/ml) of the present invention (1: CG skin, 2: CG brain, 3: CG liver, 4: CG stomach, 5: NR skin, 6: NR brain, 7: NR liver, 8: NR stomach, CG: Champsocephalus gunnari , NR: Notothenia rossii ).
2 is a graph showing the effect of increasing collagen biosynthesis of the Antarctic fish extract (25 μg/ml) of the present invention (1: CG skin, 2: CG brain, 3: CG liver, 4: CG stomach, 5: NR skin, 6 : NR brain, 7: NR liver, 8: NR stomach, CG: Champsocephalus gunnari , NR: Notothenia rossii ).
3 is a result of measuring cell viability according to treatment with the Antarctic fish extract (25 μg/ml) of the present invention after UVB (125 mJ/cm 2 ) irradiation (1: CG skin, 2: CG brain, 3: CG liver, 4: CG stomach, 5: NR skin, 6: NR brain, 7: NR liver, 8: NR stomach, CG: Champsocephalus gunnari , NR: Notothenia rossii ).
4 is a result of measuring cell viability according to treatment with the Antarctic fish extract (25 μg/ml) of the present invention after UVB (144 mJ/cm 2 ) irradiation (1: CG skin, 2: CG brain, 3: CG liver, 4: CG stomach, 5: NR skin, 6: NR brain, 7: NR liver, 8: NR stomach, CG: Champsocephalus gunnari , NR: Notothenia rossii ).
본 발명은 남극 메켈 빙어(Champsocephalus gunnari) 추출물 또는 남극 대리석무늬 암치(Notothenia rossii) 추출물을 유효성분으로 포함하는 피부 주름개선용 화장료 조성물을 제공함에 그 특징이 있다.The present invention is characterized in that it provides a cosmetic composition for improving skin wrinkles containing an extract of Antarctic Meckel smelt ( Champsocephalus gunnari ) or an extract of Antarctic marble-patterned female fish ( Notothenia rossii ) as an active ingredient.
본 발명의 “남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물”은 당업계에 공지된 추출 및 분리하는 방법을 사용하여 남극 메켈 빙어(Champsocephalus gunnari) 또는 남극 대리석무늬 암치(Notothenia rossii)로부터 직접 추출 및 분리하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된‘추출물’은 적절한 용매를 이용하여 상기 남극 어류의 피부(skin), 뇌(brain), 간(liver), 위(Stomach) 등의 다양한 부위로부터 추출한 것이며, 예를 들어, 상기 남극 어류의 다양한 부위별(피부, 뇌, 간, 위) 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다.The "Antarctic Meckel smelt extract or Antarctic marbled smelt extract" of the present invention is directly extracted and separated from Antarctic Meckel smelt ( Champsocephalus gunnari ) or Antarctic marbled smelt ( Notothenia rossii ) using an extraction and separation method known in the art. The 'extract' defined in the present invention can be obtained from various parts such as skin, brain, liver, stomach, etc. of the Antarctic fish using an appropriate solvent. extracts, and includes, for example, crude extracts of various parts (skin, brain, liver, stomach), polar solvent-soluble extracts, or non-polar solvent-soluble extracts of the Antarctic fish.
본 발명의 남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물을 추출하기 위한 적절한 용매로는 약학적으로 허용되는 유기용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있으며, 이에 제한되지는 않으나, 예를 들어, 정제수(물), 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있다. 바람직하게는 헥산을 사용하는 것이 좋다.Any pharmaceutically acceptable organic solvent may be used as a suitable solvent for extracting the Antarctic Meckel smelt extract or the Antarctic marbled female fish extract of the present invention, and water or an organic solvent may be used, but is not limited thereto. , For example, alcohol having 1 to 4 carbon atoms including purified water (water), methanol, ethanol, propanol, isopropanol, butanol, etc., acetone, Various solvents such as ether, benzene, chloroform, ethyl acetate, methylene chloride, hexane and cyclohexane can be used alone or in combination. can Preferably, it is good to use hexane.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.As an extraction method, any one of methods such as hot water extraction, cold brew extraction, reflux cooling extraction, solvent extraction, steam distillation, ultrasonic extraction, elution, and compression may be selected and used. In addition, the desired extract may be additionally subjected to a conventional fractionation process or may be purified using a conventional purification method. There is no limitation on the preparation method of the extract of the present invention, and any known method may be used.
예를 들면, 본 발명의 남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물은 상기한 열수 추출 또는 용매 추출법으로 추출된 1차 추출물을, 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography) 등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다.For example, the Antarctic Meckel smelt extract or Antarctic marbled female fish extract of the present invention is obtained by converting the primary extract extracted by the hot water extraction or solvent extraction method into a powder state by an additional process such as vacuum distillation and freeze drying or spray drying. can be manufactured In addition, a fraction further purified from the primary extract using various chromatography methods such as silica gel column chromatography, thin layer chromatography, and high performance liquid chromatography you can also get
따라서 본 발명에 있어서 남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, the Antarctic Meckel smelt extract or the Antarctic marbled female fish extract is a concept that includes all extracts, fractions, and purified products obtained in each step of extraction, fractionation, or purification, and dilutions, concentrates, or dried products thereof.
본 발명의 일 구체예에서, 상기 추출물은 남극 메켈 빙어(Champsocephalus gunnari) 또는 남극 대리석무늬 암치(Notothenia rossii)의 피부, 뇌, 간 및 위 조직을 동결·건조한 다음, 분쇄 후 헥산을 가하여 추출할 수 있다.In one embodiment of the present invention, the extract is obtained by freezing and drying the skin, brain, liver and stomach tissues of Antarctic Meckel smelt ( Champsocephalus gunnari ) or Antarctic marbled female fish ( Notothenia rossii ), and then pulverizing and then adding hexane to extract. there is.
본 발명자는 남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물이 콜라겐 생합성 증대 효과 및 MMP-1 저해 활성을 가지며(실험예 1 참조), UVB 조사에 따른 세포보호 효과를 가짐을(실험예 2 참조) 실험을 통해 입증하였다.The present inventors found that the Antarctic Meckel smelt extract or the Antarctic marble-patterned mackerel extract had collagen biosynthesis increasing effect and MMP-1 inhibitory activity (see Experimental Example 1), and cell protection effect according to UVB irradiation (see Experimental Example 2). proved through
본 발명의 조성물은 남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물 뿐만 아니라, 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.The composition of the present invention may include ingredients commonly used in cosmetic compositions, as well as Antarctic Meckel smelt extract or Antarctic marbled smelt extract, such as antioxidants, stabilizers, solubilizers, vitamins, pigments, and fragrances. A phosphorus adjuvant, and a carrier may be included.
또한, 본 발명의 조성물은 상술한 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물) 이외에, 유효성분과 반응하여 피부보호 효과를 손상시키지 않는 한도에서 종래부터 사용되어오던 피부보호제를 혼합하여 사용할 수도 있다.In addition, the composition of the present invention, in addition to the above-mentioned active ingredients (Antarctic Meckel smelt extract or Antarctic marble-patterned female fish extract), may be used by mixing a skin protectant that has been used conventionally to the extent that it does not damage the skin protection effect by reacting with the active ingredient. there is.
본 발명의 화장료 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 수렴화장수, 유연화장수, 영양화장수, 각종크림, 에센스, 팩, 파운데이션 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.Products to which the cosmetic composition of the present invention can be added include, for example, cosmetics such as astringent lotion, softening lotion, nutrient lotion, various creams, essences, packs, foundations, etc., as well as cosmetics such as cleansing, face wash, soap, treatment, and beauty essence. etc.
본 발명의 화장료 조성물의 구체적인 제형으로서는 유연 화장수, 젤, 수용성 리퀴드, 밀크로션, 영양크림, 마사지 크림, 에센스, 수중유 형 에멀젼, 유중수 형 에멀젼, 페이스크성 무수 생성물, 고체 무수 생성물, 소구체를 사용한 수성 상에서의 오일 분산물, 이온성 지질 소포체, 비이온성 지질 소포체, 연고, 클렌징 폼, 클렌징 워터, 팩, 보디오일, 수중유 형 메이크업베이스, 유중수 형 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도우, 마스카라, 치크칼라 및 아이브로우펜슬류로 이루어진 군 중에서 선택되는 1종의 제형을 포함한다.Specific formulations of the cosmetic composition of the present invention include flexible lotion, gel, water-soluble liquid, milk lotion, nourishing cream, massage cream, essence, oil-in-water emulsion, water-in-oil emulsion, facial anhydrous product, solid anhydrous product, spherules Oil dispersions in the aqueous phase used, ionic lipid vesicles, nonionic lipid vesicles, ointments, cleansing foams, cleansing water, packs, body oils, oil-in-water makeup bases, water-in-oil makeup bases, foundations, skin covers, lipsticks, It includes one formulation selected from the group consisting of lip gloss, face powder, two-way cake, eye shadow, mascara, cheek color, and eyebrow pencil.
본 발명의 바람직한 구현예에 따르면, 본 발명의 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물)의 함량은 조성물 총 중량에 대하여 0.0001-20중량%이며, 바람직하게는 0.5-20%이며, 보다 바람직하게는 1.0-20중량%이다. 상기 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물)의 함량이 0.0001중량% 미만이면 주름개선 효과가 크게 감소되고, 20중량%를 초과하는 경우에는 피부 자극을 초래할 수 있으며, 제형상의 문제점이 발생할 수 있다.According to a preferred embodiment of the present invention, the content of the active ingredient (Antarctic Meckel smelt extract or Antarctic marbled female fish extract) of the present invention is 0.0001-20% by weight, preferably 0.5-20%, based on the total weight of the composition, More preferably, it is 1.0-20 weight%. If the content of the active ingredient (Antarctic Meckel smelt extract or Antarctic marble-patterned female fish extract) is less than 0.0001% by weight, the wrinkle improvement effect is greatly reduced, and if it exceeds 20% by weight, it may cause skin irritation, and problems in formulation this can happen
한편, 본 발명에 따른 상기 화장료 조성물은 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물)을 나노리포좀 내부에 함유시켜 안정화하여 제형화할 수도 있다. 상기 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물)을 나노리포좀 내부에 함유시키면, 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물)의 성분이 안정화되어 제형화시 침전형성, 변색, 변취 등의 문제점을 해결할 수 있으며, 성분의 용해도 및 경피흡수율을 높일 수 있어 상기 추출물로부터 기대되는 효능을 최대로 발현시킬 수 있다.On the other hand, the cosmetic composition according to the present invention may be formulated by stabilizing the active ingredient (Antarctic Meckel smelt extract or Antarctic marble-patterned mackerel extract) inside the nanoliposome. When the active ingredient (Antarctic Meckel smelt extract or Antarctic marbled smelt extract) is contained inside the nanoliposome, the components of the active ingredient (Antarctic Meckel smelt extract or Antarctic marbled smelt extract) are stabilized, resulting in formation of sediment, discoloration, Problems such as off-odor can be solved, and the solubility and transdermal absorption rate of components can be increased, so that the efficacy expected from the extract can be maximized.
본 발명에서 나노리포좀은 통상적인 리포좀의 형태를 갖는 것으로서 평균 입자 지름이 10~500nm인 리포좀을 의미한다. 본 발명의 바람직한 구현 예에 따르면, 나노리포좀의 평균 입자 지름은 50~300nm이다. 나노리포좀의 평균 입자 지름이 300nm를 초과하는 경우에는 본 발명에서 달성하고자 하는 기술적 효과 중 피부침투의 개선 및 제형 안정성의 개선이 매우 미약하다.In the present invention, the nanoliposome has the form of a conventional liposome, and means a liposome having an average particle diameter of 10 to 500 nm. According to a preferred embodiment of the present invention, the average particle diameter of the nanoliposome is 50 to 300 nm. When the average particle diameter of the nanoliposome exceeds 300 nm, improvement of skin penetration and improvement of formulation stability among the technical effects to be achieved in the present invention are very weak.
본 발명에 따라 상기 추출물을 안정화하는데 사용되는 나노리포좀은 폴리올, 유성성분, 계면활성제, 인지질, 지방산 및 물을 포함하는 혼합물에 의해 제조될 수 있다.According to the present invention, the nanoliposome used to stabilize the extract may be prepared by a mixture containing a polyol, an oily component, a surfactant, a phospholipid, a fatty acid, and water.
본 발명의 나노리포좀에 이용되는 폴리올은 특히 제한되지 않으며, 바람직하게는 프로필렌글리콜, 디프로필렌글리콜, 1,3-부틸렌글리콜, 글리세린, 메틸프로판디올, 이소프로필렌글리콜, 펜틸렌글리콜, 에리스리톨, 자일리톨, 솔비톨 및 이의 혼합물로 구성된 군으로부터 선택된 1종 이상이다. 그 사용량은 나노리포좀 총 중량에 대하여 10~80중량%, 바람직하게는 30~70중량%이다.Polyols used in the nanoliposomes of the present invention are not particularly limited, and are preferably propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, methyl propanediol, isopropylene glycol, pentylene glycol, erythritol, and xylitol. , sorbitol, and at least one selected from the group consisting of mixtures thereof. The amount used is 10 to 80% by weight, preferably 30 to 70% by weight, based on the total weight of the nanoliposome.
본 발명의 나노리포좀의 제조에 이용되는 유성(oil) 성분은 당업계에 공지된 다양한 오일이 이용될 수 있으며, 바람직하게는 헥사데칸 및 파라핀 오일과 같은 하이드로카본계 오일, 에스테르계의 합성오일, 디메치콘 및 사이크로메치콘계와 같은 실리콘 오일, 해바라기유, 옥수수유, 대두유, 아보카도유, 참깨유 및 어유와 같은 동식물성 오일, 에톡시레이티드 알킬에테르계오일, 프로폭시레이티드 알킬에테르계오일, 피토스핑고신, 스핑고신 및 스핑가닌과 같은 스핑고노이드 지질, 세레브로사이드 콜레스테롤, 시토스테롤 콜레스테릴설페이트, 시토스테릴설페이트, C10-40 지방알콜 및 이의 혼합물이다. 그 사용량은 나노리포좀 총 중량에 대하여1.0~30.0중량%일 수 있으며, 바람직하게는 3.0~20.0중량%이다.Various oils known in the art may be used as the oil component used in the preparation of the nanoliposomes of the present invention, preferably hydrocarbon-based oils such as hexadecane and paraffin oil, ester-based synthetic oils, Silicone oils such as dimethicone and cyclomethicone, animal and vegetable oils such as sunflower oil, corn oil, soybean oil, avocado oil, sesame oil and fish oil, ethoxylated alkyl ether oils, propoxylated alkyl ether oils , phytosphingosine, sphingonoid lipids such as sphingosine and sphinganine, cerebroside cholesterol, sitosterol cholesteryl sulfate, sitosteryl sulfate, C10-40 fatty alcohols and mixtures thereof. The amount used may be 1.0 to 30.0% by weight, preferably 3.0 to 20.0% by weight, based on the total weight of the nanoliposome.
본 발명의 나노리포좀의 제조에 이용되는 계면활성제는 당업계에 공지된 어떠한 것도 사용할 수 있다. 예를 들어, 음이온성 계면활성제, 양이온성 계면활성제, 양성 계면활성제 및 비이온성 계면활성제가 사용될 수 있다. 바람직하게는 음이온성 계면활성제 및 비이온성 계면활성제이다. 음이온성 계면활성제의 구체적인 예는 알킬아실글루타메이트, 알킬포스페이트, 알킬락틸레이트, 디알킬포스페이트 및 트리알킬포스페이트를 포함한다. 비이온성 계면활성제의 구체적인 예는 알콕시레이티드 알킬에테르, 알콕시레이티드 알킬에스테르, 알킬폴리글리코사이드, 폴리글리세릴에스테르 및 슈가에스테르를 포함한다. 특히 바람직한 계면활성제는 비이온성 계면활성제에 속하는 폴리솔베이트류이다. 그 사용량은 나노리포좀 총 중량에 대하여 0.1~10중량%일 수 있으며, 바람직하게는 0.5~5.0중량%이다.Any surfactant known in the art may be used as the surfactant used in the preparation of the nanoliposome of the present invention. For example, anionic surfactants, cationic surfactants, amphoteric surfactants and nonionic surfactants may be used. Preferred are anionic surfactants and nonionic surfactants. Specific examples of anionic surfactants include alkylacylglutamates, alkylphosphates, alkylactylates, dialkylphosphates and trialkylphosphates. Specific examples of nonionic surfactants include alkoxylated alkyl ethers, alkoxylated alkyl esters, alkyl polyglycosides, polyglyceryl esters and sugar esters. Particularly preferred surfactants are polysorbates belonging to nonionic surfactants. The amount used may be 0.1 to 10% by weight, preferably 0.5 to 5.0% by weight, based on the total weight of the nanoliposome.
본 발명의 나노리포좀의 제조에 이용되는 또 다른 성분인 인지질은 양쪽친화성 지질이 이용되며, 천연 인지질(예를 들어, 난황 레시틴 또는 대두 레시틴, 스핑고마이엘린) 및 합성 인지질(예를 들어, 디팔미토일포스파티딜콜린 또는 수첨 레시틴)을 포함하며, 바람직하게는 레시틴이다. 특히, 대두 또는 난황에서 추출한 천연 유래의 불포화 레시틴 또는 포화 레시틴이 바람직하다. 통상적으로 천연 유래의 레시틴은 포스파티딜콜린의 양이 23~95%, 그리고 포스파디딜에탄올아민의 양이 20% 이하이다. 본 발명의 나노리포좀의 제조에 있어서, 인지질의 사용량은 나노리포좀 총 중량에 대하여 0.5~20.0중량%이며, 바람직하게는 2.0~8.0중량%이다.Phospholipids, which are another component used in the preparation of the nanoliposomes of the present invention, are amphiphilic lipids, natural phospholipids (e.g., egg yolk lecithin or soybean lecithin, sphingomyelin) and synthetic phospholipids (e.g., dipalmitoylphosphatidylcholine or hydrogenated lecithin), preferably lecithin. In particular, unsaturated or saturated lecithin of natural origin extracted from soybean or egg yolk is preferred. Typically, naturally-derived lecithin has an amount of phosphatidylcholine of 23 to 95% and an amount of phosphatidylethanolamine of 20% or less. In the preparation of the nanoliposome of the present invention, the amount of phospholipid used is 0.5 to 20.0% by weight, preferably 2.0 to 8.0% by weight, based on the total weight of the nanoliposome.
본 발명의 나노리포좀 제조에 이용되는 지방산은 고급 지방산으로서, 바람직하게는 C12-22 알킬 체인의 포화 또는 불포화 지방산으로서, 예컨대, 라우린산, 미리스트산, 팔미트산, 스테아린산, 올레산 및 리놀레산을 포함한다. 그 사용량은 나노리포좀 총 중량에 대하여 0.05~3.0중량%일 수 있으며, 바람직하게는 0.1~1.0중량%이다.The fatty acids used in the preparation of nanoliposomes of the present invention are higher fatty acids, preferably C12-22 alkyl chain saturated or unsaturated fatty acids, such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid and linoleic acid. include The amount used may be 0.05 to 3.0% by weight, preferably 0.1 to 1.0% by weight, based on the total weight of the nanoliposome.
본 발명의 나노리포좀의 제조에 이용되는 물은 일반적으로 탈이온화된 증류수이며, 그 사용량은 나노리포좀 총 중량에 대하여 5.0~40중량%일 수 있다.Water used in the preparation of the nanoliposome of the present invention is generally deionized distilled water, and the amount used may be 5.0 to 40% by weight based on the total weight of the nanoliposome.
나노리포좀의 제조는 당업계에 공지된 다양한 방법을 통해 이루어질 수 있으나, 가장 바람직하게는 상기 성분들을 포함하는 혼합물을 고압 호모게나이저에 적용하여 제조된다. 고압 호모게나이저에 의한 나노리포좀의 제조는 소망하는 입자 크기에 따라 다양한 조건(예: 압력, 횟수 등)으로 실시할 수 있으며, 바람직하게는 600~1200bar의 압력 하에서 1~5회 고압 호모게나아저를 통과하도록 하여 나노리포좀을 제조할 수 있다.Nanoliposomes may be prepared through various methods known in the art, but most preferably, they are prepared by applying a mixture containing the above components to a high-pressure homogenizer. The preparation of nanoliposomes by a high-pressure homogenizer can be carried out under various conditions (e.g., pressure, number of times, etc.) depending on the desired particle size, preferably 1 to 5 times under a pressure of 600 to 1200 bar. Nanoliposomes can be prepared by passing through.
본 발명에 따른 피부주름 개선 화장료 조성물은 상기 유효성분(남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물)을 나노리포좀 충 중량 기준으로 0.1~20.0중량%로 함유할 수 있다.The cosmetic composition for improving skin wrinkles according to the present invention may contain 0.1 to 20.0% by weight of the active ingredient (Antarctic Merkel smelt extract or Antarctic marble-patterned female fish extract) based on the total weight of nanoliposomes.
이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. These examples are intended to explain the present invention in more detail, and the scope of the present invention is not limited to these examples.
<실시예 1><Example 1>
본 발명의 남극 어류 추출물 제조Preparation of Antarctic fish extract of the present invention
냉동상태의 남극 어류 Notothenia rossii(이하 간략하게 ‘NR’이라 약칭함) 및 Champsocephalus gunnari(이하 간략하게 ‘CG’라 약잉함)를 각각 5마리씩 해동시켰다. NR의 경우 남극 세종과학기지 연안에서 직접 채집하였고, CG의 경우 크릴을 어업을 하고 있는 원양어업 업체로부터 부수어획된 어류를 전달받았다. 각 개체별로 해부해 조직 시료(피부, 뇌, 간, 위)를 얻어 각 부위를 증류수를 이용해 세척한 뒤 동결건조시켰다. 건조된 조직 시료로부터 각각 NR: 피부 13.20 g, 뇌 0.35 g, 간 2.74 g, 위 3.12 g, CG: 피부 8.50 g, 뇌 0.22 g, 간 8.36 g, 위 2.78 g을 얻었다. 각 시료를 막자사발을 이용하여 잘게 부순 후 200 mL 유리병에 각각 옮겨 담은 뒤 95% 헥산을 200 mL씩 넣고 하루 2회 반복하여 상온에서 추출하였다(24 hr X 2). 상기 과정을 통해 수득한 각각의 추출물들은 둥근 플라스크에 옮겨 담아 감압농축기를 이용하여 용매를 완전히 제거하였다. 용매가 제거된 농축된 추출물로 NR: 피부 0.18 g, 뇌 0.13 g, 간 0.24 g, 위 0.21 g, CG: 피부 0.41 g, 뇌 0.08 g, 간 1.78 g, 위 0.52 g을 최종적으로 수득하였으며, 이를 이용하여 실험을 진행하였다.Frozen Antarctic fish Notothenia rossii (hereinafter simply abbreviated as 'NR') and Champsocephalus gunnari (hereinafter simply abbreviated as 'CG') were each thawed. In the case of NR, it was directly collected from the coast of King Sejong Station in Antarctica, and in the case of CG, by-caught fish was delivered from a deep-sea fishing company that fishes krill. Each individual was dissected to obtain tissue samples (skin, brain, liver, stomach), washed with distilled water, and freeze-dried. From the dried tissue samples, NR: skin 13.20 g, brain 0.35 g, liver 2.74 g, stomach 3.12 g, CG: skin 8.50 g, brain 0.22 g, liver 8.36 g, stomach 2.78 g, respectively. After each sample was crushed using a mortar and pestle, each was transferred to a 200 mL glass bottle, and then 200 mL of 95% hexane was added and extracted twice a day at room temperature (24 hr X 2). Each of the extracts obtained through the above process was transferred to a round flask and the solvent was completely removed using a vacuum concentrator. As a concentrated extract from which the solvent was removed, NR: skin 0.18 g, brain 0.13 g, liver 0.24 g, stomach 0.21 g, CG: skin 0.41 g, brain 0.08 g, liver 1.78 g, stomach 0.52 g were finally obtained, which Experiments were conducted using
<실험예 1><Experimental Example 1>
본 발명의 남극 어류 추출물의 주름개선 효과Anti-wrinkle effect of the Antarctic fish extract of the present invention
본 실험에서는 상기 <실시예 1>을 통해 제조된 본 발명의 남극 어류 추출물의 피부주름 개선효능을 살펴보았다.In this experiment, the skin wrinkle improvement effect of the Antarctic fish extract of the present invention prepared through <Example 1> was examined.
<1-1> MMP-1 저해 활성 측정<1-1> Measurement of MMP-1 inhibitory activity
피부 주름 개선효능을 콜라겐을 분해하여 소멸시키는 콜라게나아제 효소 중의 하나인 matrix metalloproteinase-1(이하 간략하게 ‘MMP-1’라 약칭함)에 대한 억제효능으로 평가하였다. The skin wrinkle improvement effect was evaluated by the inhibitory effect on matrix metalloproteinase-1 (hereinafter simply abbreviated as 'MMP-1'), one of the collagenase enzymes that decompose and destroy collagen.
자세하게는, 인간 피부 섬유아세포(Normal Human Dermal Fibroblasts, 이하 간략하게 ‘NHDF’라 약칭함)를 UVB 125 mJ/cm2로 처리한 다음 상기 <실시예 1>을 통해 제조된 총 8종류의 남극 어류 추출물을 25μg/ml 농도로 처리하여 총 72시간 동안 배양한 다음, 각 웰에서 세포 배지를 채취하였으며, 시판되는 ELISA 키트(Human Total MMP-1 kit)를 이용하여 컨디셔닝 된 배지를 사용하여 MMP-1의 농도를 각 샘플별로 3번씩 분석하였다.Specifically, a total of 8 types of Antarctic fish prepared through <Example 1> after treating Normal Human Dermal Fibroblasts (hereinafter simply abbreviated as 'NHDF') with UVB of 125 mJ/cm 2 . The extract was treated at a concentration of 25μg/ml and cultured for a total of 72 hours, then the cell medium was collected from each well, and the medium conditioned using a commercially available ELISA kit (Human Total MMP-1 kit) was used to obtain MMP-1 The concentration of was analyzed three times for each sample.
그 결과 도 1 및 표 2에서 나타낸 바와 같이, UVB를 처리하는 경우 MMP-1이 두드러지게 증대되었으며, UVB 처리에 의해 증대된 MMP-1가 본 발명의 8종류의 남극 어류 추출물 처리에 따라 유의하게 감소되는 것을 확인하였다. As a result, as shown in FIG. 1 and Table 2, MMP-1 was remarkably increased when treated with UVB, and MMP-1 increased by UVB treatment was significantly increased according to the treatment of the 8 types of Antarctic fish extracts of the present invention. confirmed to decrease.
(UVB-)NCtr
(UVB-)
(UVB+)Ctr
(UVB+)
<1-2> 콜라겐 생합성 정도 측정<1-2> Measurement of degree of collagen biosynthesis
콜라겐은 세포 내에서 프로콜라겐으로 합성된 후, 세포 외로 분비되어 콜라겐 섬유로 중합된다. 이러한 콜라겐은 피부를 구성하는 구조단백질로서 콜라겐의 피부 내 함유량이 높을 경우, 콜라겐 분해효소의 활성이 낮을 경우 피부의 주름이 개선된다. 본 실험에서는 피부 주름 개선효능을 살펴보기 위하여, 콜라겐 생합성 정도를 Procollagen type-IC peptide(이하 간략하게 ‘PIP’라 약칭함) 측정을 통해 확인하였다.Collagen is synthesized into procollagen within the cell, then secreted out of the cell and polymerized into collagen fibers. Such collagen is a structural protein constituting the skin, and wrinkles of the skin are improved when the content of collagen in the skin is high and the activity of collagenase is low. In this experiment, in order to examine the skin wrinkle improvement effect, the degree of collagen biosynthesis was confirmed by measuring the Procollagen type-IC peptide (hereinafter simply abbreviated as 'PIP').
자세하게는, NHDF를 UVB 144 mJ/cm2로 처리한 다음 상기 <실시예 1>을 통해 제조된 총 8종류의 남극 어류 추출물을 25μg/ml 농도로 처리하여 총 72시간 동안 배양한 다음, 각 웰에서 세포 배지를 채취하였으며, 시판되는 ELISA 키트(R&D Systems Inc.; Procollagen)를 이용하여 컨디셔닝 된 배지를 사용하여 PIP의 양을 각 샘플별로 3번씩 분석하였다.In detail, NHDF was treated with UVB of 144 mJ/cm 2 and then treated with a total of 8 types of Antarctic fish extracts prepared in <Example 1> at a concentration of 25 μg/ml and cultured for a total of 72 hours, then each well The cell medium was collected from, and the amount of PIP was analyzed three times for each sample using a medium conditioned using a commercially available ELISA kit (R&D Systems Inc.; Procollagen).
그 결과 도 2 및 표 3에서 나타낸 바와 같이, UVB를 처리하는 경우 PIP 양이 두러지게 감소되는 것을 확인하였으며, UV 조사 후 본 발명의 남극 어류 추출물을 처리한 경우 추출물 5(NR 피부), 추출물 7(NR 간) 및 추출물 8(NR 위)을 각각 처리한 실험군에서 유의적으로 증대된 PIP 양을 보여주었다. As a result, as shown in FIG. 2 and Table 3, it was confirmed that the amount of PIP was remarkably reduced when UVB was treated, and when the Antarctic fish extract of the present invention was treated after UV irradiation, extract 5 (NR skin) and extract 7 (NR liver) and extract 8 (NR top) showed a significantly increased amount of PIP in the experimental group.
(UVB-)NCtr
(UVB-)
(UVB+)Ctr
(UVB+)
<실험예 2><Experimental Example 2>
본 발명의 남극 어류 추출물의 세포보호 효과Cytoprotective effect of the Antarctic fish extract of the present invention
본 실험에서는 상기 <실시예 1>을 통해 제조된 총 8종류의 남극 어류 추출물의 UVB 조사에 따른 세포보호 효과를 알아보기 위하여, 세포생존율을 MTT 분석을 통해 조사하였다.In this experiment, in order to examine the cell protection effect according to UVB irradiation of a total of 8 types of Antarctic fish extracts prepared in <Example 1>, cell viability was investigated through MTT assay.
인간 피부 섬유아세포주인 NHDF(Normal Human Dermal Fibroblasts) 세포를 UVB 125 mJ/cm2 또는 144 mJ/cm2로 처리한 다음, 상기 <실시예 1>을 통해 제조된 총 8종류의 남극 어류 추출물을 25μg/ml 농도로 처리하여 총 72시간 동안 배양하였다. 이후 배지를 제거하고 200μL의 1 mg/mL MTT 용액을 각 웰에 첨가한 후, 5% CO2의 존재 하에 37℃에서 2시간 동안 반응시켰다. 이후, 기질 함유 배지를 제거하고 200 μL의 DMSO를 각 웰에 첨가하여 포르마잔 결정을 용해시켰다. 플레이트를 실온에서 10분 동안 오비탈 쉐이커에서 흔들어주었다. DMSO에 용해된 포르마잔 100 μL 분취량의 흡광도는 ELISA 판독기(Molecular Devices E09090, San Francisco, CA, USA)를 사용하여 570nm에서 광학 밀도 (OD)를 측정하여 정량화시켰다.NHDF (Normal Human Dermal Fibroblasts) cells, a human skin fibroblast cell line, were treated with UVB 125 mJ/cm 2 or After treatment with 144 mJ/cm 2 , a total of 8 types of Antarctic fish extracts prepared in <Example 1> were treated at a concentration of 25 μg/ml and cultured for a total of 72 hours. Then, the medium was removed, and 200 μL of 1 mg/mL MTT solution was added to each well, followed by reaction at 37° C. for 2 hours in the presence of 5% CO 2 . Thereafter, the substrate-containing medium was removed and 200 μL of DMSO was added to each well to dissolve the formazan crystals. The plate was shaken on an orbital shaker for 10 minutes at room temperature. The absorbance of 100 μL aliquots of formazan dissolved in DMSO was quantified by measuring the optical density (OD) at 570 nm using an ELISA reader (Molecular Devices E09090, San Francisco, CA, USA).
그 결과 도 3에서 나타낸바와 같이, UVB(125 mJ/cm2) 조사에 의해 세포생존율(%)이 약 25% 정도 감소한 것을 확인할 수 있었고, UV 조사 후 본 발명의 남극 어류 추출물을 처리한 경우 추출물 1(CG Skin), 추출물 6(NR Brain)을 제외하고 UVB 조사만 한 것에 비해 세포생존율(%)이 증가한 것을 확인하였다. 특히, 추출물 2(CG 뇌), 추출물 4(CG 위), 추출물 8(NR 위)을 처리한 실험군에서 유의적으로 증대된 세포생존율(%)을 보여주었으며, 이를 통해 본 발명의 남극 어류 추출물 중 추출물 2(CG 뇌), 추출물 4(CG 위), 추출물 8(NR 위)의 경우 25μg/ml 농도에서 자외선으로부터 세포를 보호하는 효과가 있을 것으로 판단하였다.As a result, as shown in FIG. 3, it was confirmed that the cell viability (%) was reduced by about 25% by UVB (125 mJ/cm 2 ) irradiation, and when the Antarctic fish extract of the present invention was treated after UV irradiation, the extract Excluding 1 (CG Skin) and extract 6 (NR Brain), it was confirmed that the cell viability (%) increased compared to UVB irradiation alone. In particular, the experimental group treated with extract 2 (CG brain), extract 4 (CG stomach), and extract 8 (NR stomach) showed significantly increased cell viability (%), and through this, among the Antarctic fish extracts of the present invention, In the case of extract 2 (CG brain), extract 4 (CG top), and extract 8 (NR top), it was judged to have an effect of protecting cells from ultraviolet rays at a concentration of 25 μg / ml.
또한, 도 4에서 나타낸 바와 같이, UVB(144 mJ/cm2) 조사에 의해 세포생존율(%)이 약 25% 정도 감소한 것을 확인할 수 있었고, UV 조사 후 본 발명의 남극 어류 추출물을 처리한 경우 모든 실험군에서 UVB 조사만 한 것에 비해 세포생존율(%)이 증가한 것을 확인하였다.In addition, as shown in FIG. 4, it was confirmed that the cell viability (%) was reduced by about 25% by UVB (144 mJ/cm 2 ) irradiation, and when the Antarctic fish extract of the present invention was treated after UV irradiation, all It was confirmed that the cell viability (%) increased in the experimental group compared to UVB irradiation alone.
상기와 같은 결과를 통해, 본 발명의 남극 어류 추출물의 경우 UVB 조사에 따른 세포보호 효과가 있으며, 세포독성이 없는 것을 확인할 수 있었다.Through the above results, in the case of the Antarctic fish extract of the present invention, it was confirmed that there was a cytoprotective effect according to UVB irradiation and no cytotoxicity.
<실험예 3><Experimental Example 3>
본 발명의 남극 어류 추출물의 지방산 분석Fatty Acid Analysis of Antarctic Fish Extracts of the Present Invention
지방산 분석은 Folch 등의 방법에 따라 지질 추출하였다(J. Folch, M. Lees, G. H. S. Stanley. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 497-509.).For fatty acid analysis, lipids were extracted according to the method of Folch et al. (J. Folch, M. Lees, G. H. S. Stanley. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 497-509 .).
간략하게는, Boron trifluoride-methanol 용액 (BF3- MeOH, 14%)으로 methyl ester화하여 가스크로마토그라피 (Varian(3400) / Shimadzu (GC-17A))로 분석하였으며, 지방산의 동정은 동일조건 아래에서 표준품의 retention time과 비교하여 peak 면적비로 산출하였다. 분석은 Omegawax 250 (0.25 mm×30 m)를 사용하여, 컬럼온도 180℃, 주입부온도 250℃, 검출기온도 250℃, 승온조건 180℃(8min)→3℃/min→225℃(15min), split 100:1의 조건을 사용하였다.Briefly, methyl esterification was performed with Boron trifluoride-methanol solution (BF3- MeOH, 14%) and analyzed by gas chromatography (Varian (3400) / Shimadzu (GC-17A)), and the identification of fatty acids was performed under the same conditions. The peak area ratio was calculated by comparing the retention time of the standard product. Analysis was performed using Omegawax 250 (0.25 mm × 30 m), column temperature 180 ℃, inlet temperature 250 ℃, detector temperature 250 ℃, heating conditions 180 ℃ (8min) → 3 ℃ / min → 225 ℃ (15min), A condition of split 100:1 was used.
그 결과는 하기 표 4에서 자세히 나타내었다.The results are shown in detail in Table 4 below.
제형예 1: 유연화장수(스킨로션)Formulation Example 1: Soft lotion (skin lotion)
하기 표에 나타난 바와 같이 유연화장수를 통상의 방법에 따라 제조하였다.As shown in the table below, softening lotion was prepared according to a conventional method.
제형예 2: 영양화장수(밀크로션)Formulation Example 2: Nutrition lotion (milk lotion)
하기 표에 나타난 바와 같이 영양화장수를 통상의 방법에 따라 제조하였다.As shown in the table below, nutrient lotion was prepared according to a conventional method.
제형예 3: 영양크림Formulation Example 3: Nutrition Cream
하기 표에 나타난 바와 같이 영양크림을 통상의 방법에 따라 제조하였다.As shown in the table below, a nutritious cream was prepared according to a conventional method.
제형예 4: 마사지크림Formulation Example 4: Massage Cream
하기 표에 나타난 바와 같이 마사지크림을 통상의 방법에 따라 제조하였다.As shown in the table below, a massage cream was prepared according to a conventional method.
제형예 5: 팩Formulation Example 5: Pack
하기 표에 나타난 바와 같이 팩을 통상의 방법에 따라 제조하였다.As shown in the table below, packs were prepared according to conventional methods.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, the present invention has been looked at with respect to its preferred embodiments. Those of ordinary skill in the art to which the present invention pertains will understand that the present invention can be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments should be considered from an illustrative rather than a limiting point of view. The scope of the present invention is shown in the claims rather than the foregoing description, and all differences within the equivalent scope will be construed as being included in the present invention.
Claims (5)
상기 추출물은 탄소수 1 내지 4의 저급 알코올, 에틸아세테이트, 아세톤, 물 및 헥산으로 이루어진 군으로부터 선택된 1종 이상의 용매로 추출된 것을 특징으로 피부 주름개선용 화장료 조성물.According to claim 1,
The extract is a cosmetic composition for improving skin wrinkles, characterized in that extracted with one or more solvents selected from the group consisting of lower alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, water and hexane.
상기 추출물은 콜라겐 생합성 증대 효과 및 MMP-1 저해 활성을 갖는 것을 특징으로 하는 피부 주름개선용 화장료 조성물.According to claim 1,
The extract is a cosmetic composition for improving skin wrinkles, characterized in that it has a collagen biosynthesis enhancing effect and MMP-1 inhibitory activity.
상기 추출물은 자외선으로부터 세포를 보호하는 효과를 갖는 것을 특징으로 하는 피부 주름개선용 화장료 조성물.According to claim 1,
The extract is a cosmetic composition for improving skin wrinkles, characterized in that it has an effect of protecting cells from ultraviolet rays.
상기 화장료 조성물은 유연 화장수, 젤, 수용성 리퀴드, 밀크로션, 영양크림, 마사지 크림, 에센스, 수중유 형 에멀젼, 유중수 형 에멀젼, 페이스크성 무수 생성물, 고체 무수 생성물, 소구체를 사용한 수성 상에서의 오일 분산물, 이온성 지질 소포체, 비이온성 지질 소포체, 연고, 클렌징 폼, 클렌징 워터, 팩, 보디오일, 수중유 형 메이크업베이스, 유중수 형 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도우, 마스카라, 치크칼라 및 아이브로우펜슬류로 이루어진 군 중에서 선택되는 1종의 제형인 것을 특징으로 하는 피부 주름개선용 화장료 조성물.According to any one of claims 1 to 4,
The cosmetic composition is a flexible lotion, gel, water-soluble liquid, milk lotion, nourishing cream, massage cream, essence, oil-in-water emulsion, water-in-oil emulsion, facial anhydrous product, solid anhydrous product, oil in aqueous phase using spherules Dispersion, ionic lipid vesicles, nonionic lipid vesicles, ointment, cleansing foam, cleansing water, pack, body oil, oil-in-water makeup base, water-in-oil makeup base, foundation, skin cover, lipstick, lip gloss, face powder , A cosmetic composition for improving skin wrinkles, characterized in that it is one type of formulation selected from the group consisting of two-way cake, eye shadow, mascara, cheek color and eyebrow pencils.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210091068A KR102577747B1 (en) | 2021-07-12 | 2021-07-12 | Cosmetic composition comprising champsocephalus gunnari extract or notothenia rossii extract as an active ingredient for improving wrinkles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210091068A KR102577747B1 (en) | 2021-07-12 | 2021-07-12 | Cosmetic composition comprising champsocephalus gunnari extract or notothenia rossii extract as an active ingredient for improving wrinkles |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230010471A true KR20230010471A (en) | 2023-01-19 |
KR102577747B1 KR102577747B1 (en) | 2023-09-12 |
Family
ID=85078243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210091068A KR102577747B1 (en) | 2021-07-12 | 2021-07-12 | Cosmetic composition comprising champsocephalus gunnari extract or notothenia rossii extract as an active ingredient for improving wrinkles |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102577747B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230020834A (en) * | 2021-08-04 | 2023-02-13 | 한국해양과학기술원 | An antibacterial composition comprising champsocephalus gunnari extract or notothenia rossii extract |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5710197B2 (en) * | 1979-02-05 | 1982-02-25 | ||
KR20030016259A (en) * | 2000-05-12 | 2003-02-26 | 벵트 크리스터 올손 | Combined marine and plant extract composition |
JP2003171256A (en) * | 2001-12-03 | 2003-06-17 | Nonogawa Shoji Kk | Skin care preparation |
KR20120113537A (en) * | 2011-04-05 | 2012-10-15 | 조선대학교산학협력단 | Cosmetics composition comprising fish extract |
KR101211972B1 (en) * | 2011-07-08 | 2012-12-12 | 주식회사 뉴메디온 | Cosmetic composition containing the ultra high-pressure extract of fish eyeball |
KR20180008557A (en) | 2015-06-11 | 2018-01-24 | (주)셀트리온 | A cosmetic composition for improving wrinkles comprising ziphenoside isolated from a seven-leaf lid |
KR20200104467A (en) | 2019-02-26 | 2020-09-04 | 주식회사 리더스코스메틱 | Cosmetic Composition Containing Plumcot Extract |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5710197B2 (en) | 2009-11-16 | 2015-04-30 | 株式会社コーセー | Fish extract, rough skin improving agent, ceramide production promoter, skin external preparation containing these, cosmetics |
-
2021
- 2021-07-12 KR KR1020210091068A patent/KR102577747B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5710197B2 (en) * | 1979-02-05 | 1982-02-25 | ||
KR20030016259A (en) * | 2000-05-12 | 2003-02-26 | 벵트 크리스터 올손 | Combined marine and plant extract composition |
JP2003171256A (en) * | 2001-12-03 | 2003-06-17 | Nonogawa Shoji Kk | Skin care preparation |
KR20120113537A (en) * | 2011-04-05 | 2012-10-15 | 조선대학교산학협력단 | Cosmetics composition comprising fish extract |
KR101211972B1 (en) * | 2011-07-08 | 2012-12-12 | 주식회사 뉴메디온 | Cosmetic composition containing the ultra high-pressure extract of fish eyeball |
KR20180008557A (en) | 2015-06-11 | 2018-01-24 | (주)셀트리온 | A cosmetic composition for improving wrinkles comprising ziphenoside isolated from a seven-leaf lid |
KR20200104467A (en) | 2019-02-26 | 2020-09-04 | 주식회사 리더스코스메틱 | Cosmetic Composition Containing Plumcot Extract |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230020834A (en) * | 2021-08-04 | 2023-02-13 | 한국해양과학기술원 | An antibacterial composition comprising champsocephalus gunnari extract or notothenia rossii extract |
Also Published As
Publication number | Publication date |
---|---|
KR102577747B1 (en) | 2023-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101589002B1 (en) | Cosmetic composition containing sargassum serratifolium extract for improving skin wrinkle | |
CN101346136A (en) | Protection of oxidizable agents | |
KR20120042806A (en) | Pharmaceutical composition for treating acne | |
US11590185B2 (en) | Antioxidant composition comprising Sargassum serratifolium extract or fraction thereof as active ingredient | |
KR100501399B1 (en) | Cosmetic Compostion for Preventing Skin Aging Comprising Plant Extract as Oriental Medicine Stabilized in Nanoliposome | |
KR20120054906A (en) | Solubilization cosmetic composition containing oleanolic acid | |
KR20100064451A (en) | Composition for external skin application for improvement in wrinkle containing leontopodic acid | |
KR102577747B1 (en) | Cosmetic composition comprising champsocephalus gunnari extract or notothenia rossii extract as an active ingredient for improving wrinkles | |
KR100742267B1 (en) | Extract of Chrysanthemum morifolium Ramat, the preparation method thereof and the cosmetic composition comprising the same for whitening | |
KR100904370B1 (en) | Cosmetic Composition containing Nanoliposomes | |
KR20090009054A (en) | Cosmetic composition comprising nanovesicle vitatox which having the effect of anti-oxidation and the effect of anti- wrinkle around the eye | |
KR100858628B1 (en) | Cosmetic Composition for alleviating Skin Irritation Comprising Rumex Crispus L. Extract Stabilized in Nanoliposome | |
KR102027647B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin | |
KR101620820B1 (en) | Cosmetic Composition for Improving Skin Appearances Comprising Ginsenoside as Active Ingredient | |
KR102307139B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Chondrus crispus, Origanum majorana, Petroselinum crispum and Fumaria officinalis As Active Ingredient | |
KR102283326B1 (en) | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment | |
ES2253337T3 (en) | USING AN EXTRACT FROM AN IRIDACEA IN A COMPOSITION INTENDED TO STIMULATE IMMUNE DEFENSES. | |
KR101860001B1 (en) | Cosmetic composition comprising bamboo stem extract as an active ingredient | |
KR20200060567A (en) | Cosmetic composition including as effective ingredient an extract of sargassum muticum | |
KR20050081753A (en) | Cosmetic composition for protecting skin comprising plant extract stabilized in nanoliposome | |
KR102453959B1 (en) | Cosmetic composition comprising Castanopsis sieboldii leaves extract or its fraction as an active ingredient | |
KR20190012642A (en) | Cosmetic Composition Comprising Extract of Alpinia oxyphylla Miquel As Active Ingredient | |
KR102365222B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin, Polygonum tinctorium leaf and Betula platyphylla japonica bark extract | |
KR102365223B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin, Polygonum tinctorium leaf and Brassica napus whole plant | |
KR101549148B1 (en) | Composition for protecting and curing human keratinocyte against UV-B comprising Phryma leptostachya var. asiatica Hara ethanol extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |